Literature DB >> 10722948

Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits.

A S Monem1, F M Ali, M W Ismail.   

Abstract

The possibility of using liposomes as an ophthalmic drug delivery carrier for the lipophilic drug, pilocarpine HCl, was investigated on the eyes of normal and glaucomatous pigmented rabbits. The intraocular pressure (IOP) of rabbits was measured, using a Shi∅tz tonometer, as a function of time after topical administration with free drug, neutral and negatively charged multilamellar vesicles (MLVs) encapsulating pilocarpine HCl. The results showed that administration with neutral MLVs displayed the most prolonged effect with respect to negatively charged MLVs and free drug. The efficiency of MLVs encapsulating pilocarpine HCl, measured using spectrophotometric technique, was found to be 96% in our modified preparations. The storage stability of MLVs encapsulating pilocarpine HCl was investigated by measuring phase transition and size distribution using light scattering technique. The results show that liposomes encapsulating pilocarpine HCl have kept their integrity and physicochemical properties for at least 15 months, which makes them suitable for commercial use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722948     DOI: 10.1016/s0378-5173(99)00348-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

1.  Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.

Authors:  Ehab I Taha; Magda H El-Anazi; Ibrahim M El-Bagory; Mohsen A Bayomi
Journal:  Saudi Pharm J       Date:  2013-08-08       Impact factor: 4.330

2.  Long-acting liposomal corneal anesthetics.

Authors:  Changyou Zhan; Claudia M Santamaria; Weiping Wang; J Brian McAlvin; Daniel S Kohane
Journal:  Biomaterials       Date:  2018-08-09       Impact factor: 12.479

3.  Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.

Authors:  Luís F Neves; Jinghua Duan; Adrienne Voelker; Anil Khanal; Lacey McNally; Jill Steinbach-Rankins; Brian P Ceresa
Journal:  J Microencapsul       Date:  2016-08-10       Impact factor: 3.142

Review 4.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

5.  A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Authors:  Tali Fishman Jacob; Vijay Singh; Mudit Dixit; Tamar Ginsburg-Shmuel; Begoña Fonseca; Jesus Pintor; Moussa B H Youdim; Dan T Major; Orly Weinreb; Bilha Fischer
Journal:  Purinergic Signal       Date:  2018-07-17       Impact factor: 3.765

6.  Exploring a Novel Fasudil-Phospholipid Complex Formulated as Liposomal Thermosensitive in situ Gel for Glaucoma.

Authors:  Aya M Khallaf; Riham M El-Moslemany; Mahmoud F Ahmed; Mahmoud H Morsi; Nawal M Khalafallah
Journal:  Int J Nanomedicine       Date:  2022-01-11

7.  Recent applications of liposomes in ophthalmic drug delivery.

Authors:  Gyan P Mishra; Mahuya Bagui; Viral Tamboli; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2011-03-01

8.  Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

Authors:  John Youshia; Amany O Kamel; Abdelhameed El Shamy; Samar Mansour
Journal:  Int J Nanomedicine       Date:  2012-05-17

9.  Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.

Authors:  Liandi Huang; Huanhuan Gao; Zhigang Wang; Yixin Zhong; Lan Hao; Zhiyu Du
Journal:  Int J Nanomedicine       Date:  2021-05-26

10.  Stimuli sensitive hydrogels for ophthalmic drug delivery: A review.

Authors:  Swatantra Ks Kushwaha; Prachi Saxena; Ak Rai
Journal:  Int J Pharm Investig       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.